-
XBI Dashboard
- Holdings
SPDR(R) S&P(R) Biotech ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
State Street Navigator Securities Lending Portfolio II | 447.87 mm | 447.87 mm shares | 7.03 | Short-term investment vehicle | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 162.79 mm | 1.19 mm shares | 2.56 | Common equity | Long | USA |
ABBV AbbVie Inc. | 155.83 mm | 876.91 k shares | 2.45 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 152.90 mm | 1.66 mm shares | 2.40 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 152.35 mm | 2.32 mm shares | 2.39 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 148.97 mm | 422.19 k shares | 2.34 | Common equity | Long | USA |
BIIB Biogen Inc. | 148.50 mm | 971.10 k shares | 2.33 | Common equity | Long | USA |
MRNA Moderna, Inc. | 148.35 mm | 3.57 mm shares | 2.33 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 148.28 mm | 1.22 mm shares | 2.33 | Common equity | Long | USA |
AMGN Amgen Inc. | 145.77 mm | 559.28 k shares | 2.29 | Common equity | Long | USA |
INCY Incyte Corporation | 145.70 mm | 2.11 mm shares | 2.29 | Common equity | Long | USA |
NTRA Natera, Inc. | 144.84 mm | 914.98 k shares | 2.27 | Common equity | Long | USA |
INSM Insmed Incorporated | 142.28 mm | 2.06 mm shares | 2.23 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 141.58 mm | 601.66 k shares | 2.22 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 140.91 mm | 197.82 k shares | 2.21 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 137.48 mm | 1.68 mm shares | 2.16 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 136.04 mm | 2.42 mm shares | 2.14 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 131.49 mm | 326.51 k shares | 2.06 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 124.29 mm | 3.09 mm shares | 1.95 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 117.90 mm | 2.47 mm shares | 1.85 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 116.44 mm | 377.34 k shares | 1.83 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 113.63 mm | 3.78 mm shares | 1.78 | Common equity | Long | USA |
ADMA ADMA Biologics, Inc. | 100.24 mm | 5.84 mm shares | 1.57 | Common equity | Long | USA |
Roivant Sciences Ltd
|
96.03 mm | 8.12 mm shares | 1.51 | Common equity | Long | Bermuda |
IONS Ionis Pharmaceuticals, Inc. | 94.51 mm | 2.70 mm shares | 1.48 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 88.54 mm | 1.88 mm shares | 1.39 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 88.31 mm | 1.01 mm shares | 1.39 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 87.77 mm | 2.75 mm shares | 1.38 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 86.09 mm | 1.97 mm shares | 1.35 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 80.35 mm | 2.41 mm shares | 1.26 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 78.22 mm | 2.85 mm shares | 1.23 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
74.34 mm | 1.89 mm shares | 1.17 | Common equity | Long | Switzerland |
Alkermes PLC
|
68.66 mm | 2.39 mm shares | 1.08 | Common equity | Long | Ireland |
SMMT Summit Therapeutics Inc. | 63.36 mm | 3.55 mm shares | 0.99 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 62.05 mm | 809.12 k shares | 0.97 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 58.62 mm | 2.02 mm shares | 0.92 | Common equity | Long | USA |
Biohaven Ltd
|
57.54 mm | 1.54 mm shares | 0.90 | Common equity | Long | Virgin Islands (British) |
NUVL Nuvalent, Inc. | 52.86 mm | 675.21 k shares | 0.83 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 50.60 mm | 1.40 mm shares | 0.79 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 49.40 mm | 1.06 mm shares | 0.78 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 48.54 mm | 1.15 mm shares | 0.76 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 48.54 mm | 309.85 k shares | 0.76 | Common equity | Long | USA |
GERN Geron Corporation | 48.53 mm | 13.71 mm shares | 0.76 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 47.32 mm | 925.53 k shares | 0.74 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 46.71 mm | 6.31 mm shares | 0.73 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 45.85 mm | 6.78 mm shares | 0.72 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 44.95 mm | 1.91 mm shares | 0.71 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 43.88 mm | 1.74 mm shares | 0.69 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 42.24 mm | 998.82 k shares | 0.66 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 41.97 mm | 1.09 mm shares | 0.66 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 40.76 mm | 1.03 mm shares | 0.64 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 40.12 mm | 888.84 k shares | 0.63 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 38.44 mm | 889.40 k shares | 0.60 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 37.77 mm | 1.97 mm shares | 0.59 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 36.25 mm | 2.84 mm shares | 0.57 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 35.77 mm | 3.80 mm shares | 0.56 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 35.01 mm | 2.01 mm shares | 0.55 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 34.61 mm | 1.35 mm shares | 0.54 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 34.04 mm | 757.25 k shares | 0.53 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 33.90 mm | 2.91 mm shares | 0.53 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 33.38 mm | 2.40 mm shares | 0.52 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 32.91 mm | 1.33 mm shares | 0.52 | Common equity | Long | USA |
NVAX Novavax, Inc. | 32.81 mm | 4.08 mm shares | 0.52 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 32.80 mm | 1.61 mm shares | 0.52 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 32.14 mm | 574.05 k shares | 0.50 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 31.82 mm | 594.23 k shares | 0.50 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 31.40 mm | 1.71 mm shares | 0.49 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 31.38 mm | 1.27 mm shares | 0.49 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 30.88 mm | 6.09 mm shares | 0.48 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 29.76 mm | 656.87 k shares | 0.47 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 29.47 mm | 382.99 k shares | 0.46 | Common equity | Long | USA |
CDNA CareDx, Inc | 29.22 mm | 1.36 mm shares | 0.46 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 29.02 mm | 1.54 mm shares | 0.46 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 27.84 mm | 1.33 mm shares | 0.44 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 26.83 mm | 2.03 mm shares | 0.42 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 26.32 mm | 800.88 k shares | 0.41 | Common equity | Long | USA |
VCEL Vericel Corporation | 26.07 mm | 474.83 k shares | 0.41 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 26.07 mm | 647.92 k shares | 0.41 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 25.94 mm | 1.89 mm shares | 0.41 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 25.72 mm | 896.66 k shares | 0.40 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 24.93 mm | 1.32 mm shares | 0.39 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 23.01 mm | 826.97 k shares | 0.36 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 23.01 mm | 1.82 mm shares | 0.36 | Common equity | Long | USA |
MNKD MannKind Corporation | 22.82 mm | 3.55 mm shares | 0.36 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 22.37 mm | 1.78 mm shares | 0.35 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 21.27 mm | 514.37 k shares | 0.33 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 20.35 mm | 874.12 k shares | 0.32 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 20.12 mm | 2.67 mm shares | 0.32 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 20.04 mm | 316.05 k shares | 0.31 | Common equity | Long | USA |
CAPR Capricor Therapeutics, Inc. | 19.86 mm | 1.44 mm shares | 0.31 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 16.87 mm | 1.60 mm shares | 0.26 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 16.04 mm | 6.26 mm shares | 0.25 | Common equity | Long | USA |
EBS Emergent BioSolutions Inc. | 15.76 mm | 1.65 mm shares | 0.25 | Common equity | Long | USA |
CDMO Avid Bioservices, Inc. | 14.77 mm | 1.20 mm shares | 0.23 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 14.45 mm | 1.66 mm shares | 0.23 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 14.29 mm | 1.83 mm shares | 0.22 | Common equity | Long | USA |
XNCR Xencor, Inc. | 13.61 mm | 592.05 k shares | 0.21 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 13.29 mm | 2.63 mm shares | 0.21 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 13.18 mm | 884.87 k shares | 0.21 | Common equity | Long | USA |
ALT Altimmune, Inc. | 12.96 mm | 1.80 mm shares | 0.20 | Common equity | Long | USA |
ANNX Annexon, Inc. | 12.76 mm | 2.49 mm shares | 0.20 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 12.44 mm | 1.02 mm shares | 0.20 | Common equity | Long | USA |
Prothena Corp PLC
|
12.25 mm | 884.76 k shares | 0.19 | Common equity | Long | Ireland |
IRWD Ironwood Pharmaceuticals, Inc. | 11.95 mm | 2.70 mm shares | 0.19 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 11.71 mm | 2.84 mm shares | 0.18 | Common equity | Long | USA |
GRAL GRAIL, Inc. | 11.37 mm | 636.84 k shares | 0.18 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 11.13 mm | 656.03 k shares | 0.17 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 10.69 mm | 807.47 k shares | 0.17 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 10.66 mm | 880.58 k shares | 0.17 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 10.09 mm | 1.38 mm shares | 0.16 | Common equity | Long | USA |
IMNM Immunome, Inc. | 9.85 mm | 927.10 k shares | 0.15 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 9.13 mm | 849.80 k shares | 0.14 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 8.91 mm | 4.19 mm shares | 0.14 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 8.76 mm | 1.55 mm shares | 0.14 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 8.45 mm | 765.79 k shares | 0.13 | Common equity | Long | USA |
ArriVent Biopharma Inc
|
8.28 mm | 310.97 k shares | 0.13 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 8.26 mm | 1.07 mm shares | 0.13 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 8.26 mm | 521.68 k shares | 0.13 | Common equity | Long | USA |
ETNB 89bio, Inc. | 7.90 mm | 1.01 mm shares | 0.12 | Common equity | Long | USA |
DNTH Dianthus Therapeutics, Inc. | 7.07 mm | 324.13 k shares | 0.11 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 6.90 mm | 340.00 k shares | 0.11 | Common equity | Long | USA |
ERAS Erasca, Inc. | 6.00 mm | 2.39 mm shares | 0.09 | Common equity | Long | USA |
LENZ LENZ Therapeutics, Inc. | 5.83 mm | 201.87 k shares | 0.09 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 5.83 mm | 3.58 mm shares | 0.09 | Common equity | Long | USA |
MDXG MiMedx Group, Inc. | 5.51 mm | 572.42 k shares | 0.09 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 5.47 mm | 1.67 mm shares | 0.09 | Common equity | Long | Canada |
OLMA Olema Pharmaceuticals, Inc. | 5.41 mm | 927.52 k shares | 0.08 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 5.39 mm | 373.76 k shares | 0.08 | Common equity | Long | USA |
KalVista Pharmaceuticals Inc
|
5.25 mm | 620.37 k shares | 0.08 | Common equity | Long | USA |
SVRA Savara Inc. | 5.14 mm | 1.67 mm shares | 0.08 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 4.97 mm | 2.87 mm shares | 0.08 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 4.72 mm | 585.45 k shares | 0.07 | Common equity | Long | USA |
CELC Celcuity Inc. | 4.60 mm | 351.66 k shares | 0.07 | Common equity | Long | USA |
SGMO Sangamo Therapeutics, Inc. | 4.08 mm | 4.00 mm shares | 0.06 | Common equity | Long | USA |
AKBA Akebia Therapeutics, Inc. | 3.89 mm | 2.05 mm shares | 0.06 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 3.83 mm | 428.00 k shares | 0.06 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 3.68 mm | 469.95 k shares | 0.06 | Common equity | Long | USA |
State Street Institutional US Government Money Market Fund | 3.62 mm | 3.62 mm shares | 0.06 | Short-term investment vehicle | Long | USA |
SCLX Scilex Holding Company | 2.53 mm | 5.94 mm shares | 0.04 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 2.18 mm | 314.50 k shares | 0.03 | Common equity | Long | USA |
CONTRA INHIBRX INC | 1.07 mm | 1.65 mm shares | 0.02 | Equity derivative | N/A | USA |
CONTRA MIRATI THERAPEU | 958.69 k | 1.37 mm shares | 0.02 | Equity derivative | N/A | USA |
State Street Institutional US Government Money Market Fund | 18.69 k | 18.69 k shares | 0.00 | Short-term investment vehicle | Long | USA |
OABI OmniAb, Inc. | 0 | 161.96 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0 | 161.96 k shares | 0.00 | Common equity | Long | USA |